A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

NCT05915702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Contrast Enhancement in Magnetic Resonance Imaging
Central Nervous System Pathology

Interventions

DRUG: Gadoquatrane (BAY1747846)
DRUG: Gadobutrol
DRUG: Gadoterate meglumine
DRUG: Gadoteridol

Sponsor

Bayer